As of 2025-10-17, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (22.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -157.8%.
The range of the Relative Valuation is (17.74) - (25.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 15.6x | 13.5x |
| Forward P/E multiples | 10.7x - 17.1x | 13.4x |
| Fair Price | (17.74) - (25.66) | (22.09) |
| Upside | -146.4% - -167.1% | -157.8% |
| Date | P/E |